Discussed in
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
m_and_a·PitchBook News·SEPTEMBER 1, 2026
“Eli Lilly & Co. agreed to acquire Bain Capital Life Sciences-backed Merida Biosciences, a biotech company developing drugs for autoimmune and allergic diseases, in a $2.88 billion deal.”
Source→02
funding·Axios Pro Rata·SEPTEMBER 1, 2026
“Merida had raised $154m from Third Rock Ventures, Bain Capital Life Sciences, BVF Partners, GV, and Perceptive Advisors.”
Source→03
m_and_a·Axios Pro Rata·
AI-extracted from podcast / newsletter / paper summaries. May contain errors.